Amryt Pharma Plc Accounts Payable

Amryt Pharma Plc (AMYT) currently reports a accounts payable of $0 as of April 2023. That compares with $140M in the prior-year period — down 100.0% year over year. Use the charts on this page to explore Amryt Pharma Plc's accounts payable history and peer comparisons.

Amryt Pharma Plc's accounts payable decreased from $140M to $0 — a 100.0% year-over-year decrease (period ending April 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Amryt Pharma Plc reported $0 in accounts payable as of April 2023. That compares with $140M in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Amryt Pharma Plc, and consider following AMYT for alerts when major investors trade the stock.

Amryt Pharma Plc is classified in the Healthcare sector. On accounts payable, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AMYT with unrelated industries.